Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tsubota LaboratoryTSE:4890 +2.76%60 EV-to-EBITDA is -10.51 as of Aug. 31, 2026. GuruFocus rates TSE:4890 with a GF Score™ of 60/100 and a GF Value™ of 円95.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 520 Medical Devices & Instruments companies, Tsubota Laboratory ranks worse than 192307.5% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tsubota Laboratory's enterprise value is 円7,051.1 Mil.
Tsubota Laboratory's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円-671.0 Mil. Therefore, Tsubota Laboratory's EV-to-EBITDA for today is -10.51.
The historical rank and industry rank for Tsubota Laboratory's EV-to-EBITDA or its related term are showing as below:
TSE:4890'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -209.4 Med: -7.28 Max: 1542.95
Current: -10.51
During the past 7 years, the highest EV-to-EBITDA of Tsubota Laboratory was 1542.95. The lowest was -209.40. And the median was -7.28.
TSE:4890's EV-to-EBITDA is ranked worse than 100% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.68
vs TSE:4890: -10.51
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Tsubota Laboratory's PE Ratio (TTM) for today is calculated as:
Tsubota Laboratory's share price for today is 円298.00.
Tsubota Laboratory's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-26.990.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Tsubota Laboratory's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4890 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Tsubota Laboratory's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsubota Laboratory EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Tsubota Laboratory's EV-to-EBITDA falls into.
Tsubota Laboratory's current Enterprise Value is 円7,051.1 Mil.
Tsubota Laboratory's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-671.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsubota Laboratory (TSE:4890) has a EV-to-EBITDA of -10.51 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tsubota Laboratory. According to the industry distribution chart, Tsubota Laboratory ranks #999999 out of 520 companies in the Medical Devices & Instruments industry.
Is Tsubota Laboratory's EV-to-EBITDA too high?
Tsubota Laboratory's current EV-to-EBITDA is -10.51. Based on the distribution chart, Tsubota Laboratory ranks #999999 out of 520 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tsubota Laboratory has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tsubota Laboratory's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Tsubota Laboratory ranks #999999 out of 520 companies for EV-to-EBITDA. This places Tsubota Laboratory in the lower half of its industry. The industry median EV-to-EBITDA is 14.68. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.68, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tsubota Laboratory. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsubota Laboratory's current EV-to-EBITDA is -10.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsubota Laboratory stock overvalued right now?
Based on GuruFocus' analysis, Tsubota Laboratory (TSE:4890) is currently considered Significantly Overvalued. The stock's GF Value™ is 円95.62, compared to a current price of 円298.00 — trading 211.7% above its estimated fair value. The current EV-to-EBITDA is -10.51. Tsubota Laboratory's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Tsubota Laboratory (TSE:4890), the current EV-to-EBITDA is -10.51 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tsubota Laboratory (TSE:4890) Overvalued in 2026?
Based on GuruFocus' analysis, Tsubota Laboratory stock appears to be overvalued.
The current stock price of 円298.00 is trading 211.7% above its estimated GF Value™ of 円95.62.
GuruFocus considers Tsubota Laboratory to be Significantly Overvalued.
Key valuation signals for TSE:4890:
EV-to-EBITDA: -10.51
GF Value™: 円95.62 vs. price of 円298.00 (211.7% above fair value)
No single metric tells the full story. See the TSE:4890 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
60GF Score
Get the complete analysis for TSE:4890
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4890 has been successfully added to your 
